After the Supreme Court overturned Roe in 2022, anti-abortion advocates launched a barrage of litigation, including a federal suit in Texas aimed at mifepristone, one drug in a two-drug regimen used in medication abortions.

Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump's first term. U.S. District Judge Matthew Kacsmaryk ruled that Missouri,

Idaho, Kansas and Missouri want the federal Food and Drug Administration to prohibit telehealth prescriptions for mifepristone and require that it be used only in the first seven weeks of

Since the U.S. Supreme Court’s decision in 2022 to allow states to regulate abortion access, support for expanded access to abortion pills has significantly increased, including among those living in states with abortion bans,